A Genetic Test That Detects Hereditary Risk of Developing
Breast and Ovarian Cancer: Oncodona by Igenomix
(Attn.editors: The following press release comes to you under an arrangement with PRNewswire. PTI takes no editorial responsibility for the same).
A Genetic Test That Detects Hereditary Risk of Developing Breast and Ovarian Cancer: Oncodona by Igenomix
NEW DELHI, November 8, 2017/PRNewswire/ -- A little knowledge goes a long way!
Women always tend to forget the need to balance their own health and family. In the modern era, women want to see themselves at par with men, and they are often juggling between the office work and home chores. Due to so much of pressure that a woman faces on a daily basis, they often ignore the early signs of breast and ovarian cancer. Breast Cancer is the most common cancer among women of the modern world. Incidences of breast and ovarian cancers are increasing day by day. "In India, Breast Cancer accounts for 25% to 31% of all cancers in women," as quoted by National Health Portal (NHP).
(Logo: http://mma.prnewswire.com/media/449323/PRNE_Igenomix_Logo.jpg )
Oncodona is an advanced genetic test that can help one understand and identify the hereditary risk for developing breast and ovarian cancers. The test helps one to learn about their risk for these cancers, consult with the doctor and develop a strategy to reduce the risk or screen these diseases at an early stage.
Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2, in the process to screen harmful mutations. BRCA1 and BRCA2 are human genes that are associated with cell growth, cell division and DNA repair. Mutation changes in these genes can often result in a failure to repair the DNA that can lead to the development of cancer, especially breast and ovarian cancer.
Why to go for Oncodona test?
In the cases of hereditary ovarian and breast cancers, it is essential to perform intensive tests to screen for cancer in its early stage so that there is a higher probability of a successful treatment. In case of people with mutations, there are several preventive options to deal with the cancer risk. These measures include intensive screening for early diagnosis, lifestyle changes and even preventive actions for siblings and children.
Who should go for Oncodona test?
Oncodona is a simple and complete test for all women who want to have the maximum information about their personal risk of developing cancer. If a person has inherited a harmful mutation, it means that each of their brothers or sisters also have 50% chance of inheriting that mutation. If a family member has been identified with these two deadly cancers then they should definitely go for this simple test.
Why it is important to self-examine regularly?
No doubt consulting a doctor and getting oneself checked is important but self examinations are really important to catch breast cancer at an early stage. Performing breast self- examination at least once a month is considered wise. Any strange lump needs to be taken care of, especially if they are present for more than a week. If a lump stays for a longer period, then taking help of the doctor immediately is required.
Don't ignore the early signs; every woman is important for her family. Oncodona test is the best way to get screened.
Igenomix is a biotechnology company providing advanced services in reproductive genetics. Its consolidated experience and advanced research capabilities make it one of the world leaders in this field and guarantee the provision of effective solutions tailored to different infertility problems. It is present in Valencia (Spain), Miami, Los Angeles, New York, Mexico City, UK, Japan, Sao Paulo, Dubai and Delhi, with a workforce of over 170 professionals. Further information about the company at https://www.igenomix.co.in/
Media Contact: Divya Bhasin [email protected] +91-11-6651-7800 Marketing Manager - India & UAE Igenomix
Source: Igenomix India Pvt Ltd PRNewswire OSS
Disclaimer: This story has not been edited by BW staff and is auto-generated from a syndicated feed.